Research News

02.02.2012

Higher risk of mortality for children with PAH on a higher dose of the medicine

The manufacturer Pfizer recently tested the active substance sildenafil for the first time in a large-scale clinical study with children. We asked Dr. Oliver Miera, paediatric cardiologist and assistant medical director at the Deutsches Herzzentrum Berlin, what families with children with a congenital heart defect and PAH should know about the medicine.  Read more …

18.11.2011

Women’s hearts need earlier help

A team of researchers at the Competence Network for Congenital Heart Defects gathered gender-specific reference values for tetralogy of Fallot and realized that women have been disadvantaged in treatment practices to date. Read more …

24.06.2011

Impact of heart defects on women’s sex lives underestimated

A fulfilling sex life can significantly enhance quality of life. A team of researchers from the German Competence Network for Congenital Heart Defects has studied the degree to which congenital heart defects impact on women’s sexuality.  Read more …